VO

· Replimune, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VO, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] [Phase 3]

See pricing